Trade

Phaarmasia share price

High risk
  • 63%Low risk
  • 63%Moderate risk
  • 63%Balanced risk
  • 63%High risk
  • 63%Extreme risk
  • 79.90(4.99%)
    December 5, 2025 10:59:20 AM IST
    • NSE
    • BSE
  • Vol : 0.48 K (NSE + BSE)
    Last 20 day avg : 2.24 K

Phaarmasia is trading 4.99% upper at Rs 79.90 as compared to its last closing price. Phaarmasia has been trading in the price range of 79.90 & 79.90. Phaarmasia has given 56.91% in this year & 27.60% in the last 5 days. Phaarmasia has TTM P/E ratio 30.56 as compared to the sector P/E of 32.51.The company posted a net profit of 1.74 Crores in its last quarter.Listed peers of Phaarmasia include Dr Reddy's Laboratories (-0.04%), Cipla (-0.04%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in Phaarmasia was at -% in . The MF holding has - from the last quarter. The FII holding in Phaarmasia was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 06, 2025, 04:29 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    2.08
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
79.90
Highest
79.90
52 week range
Lowest
23.60
Highest
76.10
Phaarmasia Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dr Reddy's Laboratories
Bullish
1,276.55-0.041,06,330.4218.803.170.632.34
Cipla
Neutral
1,520.55-0.041,22,825.6523.333.940.850.81
Torrent Pharmaceuticals
Bullish
3,773.70-0.741,27,661.9766.6416.920.8417.62
Sun Pharmaceutical Industries
Bullish
1,805.00-0.754,33,140.8537.946.040.880.50
Divi's Laboratories
Bullish
6,468.25-0.041,73,113.6278.2711.470.460.01
Phaarmasia Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-14Quarterly Results
2025-08-11Quarterly Results
2025-05-28Audited Results
2025-02-14Quarterly Results
2024-11-05Quarterly Results
About the company Phaarmasia
  • IndustryBiotechnology & Drugs
  • ISININE486I01016
  • BSE Code523620
  • NSE Code
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
  • Management Info
  • Eswara Rao NagineniChief Financial Officer
  • Urvashi BhatiaChief Compliance Officer, Company Secretary
  • Maneesh SapteManaging Director
  • Yallapragada Bhaskara RaoWhole-Time Director
Phaarmasia Share Price FAQs

Phaarmasia is trading at 79.90 as on Fri Dec 05 2025 05:29:20. This is 4.99% upper as compared to its previous closing price of 76.10.

The market capitalization of Phaarmasia is 54.54 Cr as on Fri Dec 05 2025 05:29:20.

The 52 wk high for Phaarmasia is 76.10 whereas the 52 wk low is 23.60

Phaarmasia can be analyzed on the following key metrics -

  • TTM P/E: 30.56
  • Sector P/E: 32.51
  • Dividend Yield: 0.00%
  • D/E ratio: 0.00

Phaarmasia reported a net profit of -1.59 Cr in 2025.